Kimberly Gentile's Net Worth
$11.7 Million
Who is Kimberly Gentile?
Kimberly Gentile has an estimated net worth of $11.7 Million. This is based on reported shares across multiple companies, which include Biohaven Pharmaceutical Holding Co Ltd., and Biohaven Ltd..
SEC CIK
Kimberly Gentile's CIK is 0001704186
Past Insider Trading and Trends
2022 was Kimberly Gentile's most active year for acquiring shares with 32 total transactions. Kimberly Gentile's most active month to acquire stocks was the month of September. 2022 was Kimberly Gentile's most active year for disposing of shares, totalling 31 transactions. Kimberly Gentile's most active month to dispose stocks was the month of September. 2020 saw Kimberly Gentile paying a total of $408,121.10 for 53,840 shares, this is the most they've acquired in one year. In 2022 Kimberly Gentile cashed out on 425,477 shares for a total of $2,215,862.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Biohaven Pharmaceutical Holding Co Ltd. No price found
SVP, Clinical OperationsKimberly Gentile used to own units in Common Shares but no longer holds any shares there. From 2017 to 2022 Kimberly Gentile acquired a total of 131,340 shares in Biohaven Pharmaceutical Holding Co Ltd. at a cost of $446,246.10, Kimberly also disposed a total of 131,340 shares of Biohaven Pharmaceutical Holding Co Ltd. equalling to $8,639,682.10.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -11.65K |
$148.50 | -$1,730,470.50 |
0
|
Oct 3
| |||
Form 4
| +20.10% | 1.95K |
$123.86 | -$222,948.00 | 11.65K |
Jan 6 - Jan 7
| |||
Form 4
| +26.16% | 2.01K |
$115.55 | -$200,825.90 | 9.7K |
Nov 25
| |||
Form 4
| +35.21% | 2K |
$83.38 | -$145,664.86 | 7.69K |
Jan 6
| |||
Form 4
| +56.31% | 2.05K |
$90.14 | -$153,328.14 | 5.69K |
Nov 25
| |||
Form 4
|
—
|
0
|
$42.82 | -$1,575,766.99 | 3.64K |
Scheduled
|
Oct 8
| ||
Form 4
|
—
|
0
|
$37.90 | -$25,841.16 | 3.64K |
Scheduled
|
Jun 17
| ||
Form 4
|
—
|
0
|
$37.90 | -$1,550,469.60 | 3.64K |
Scheduled
|
Jun 17
| ||
Form 4
|
—
|
0
|
$37.82 | -$38,667.48 | 3.64K |
Scheduled
|
Jun 8
| ||
Form 4
| +77.60% | 1.59K |
$31.32 | $49,806.10 | 3.64K |
Jan 9
| |||
Form 4
|
∞
| 2.05K |
$52.13 | -$88,673.13 | 2.05K |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 25
| |||
Form 4
|
—
|
0
|
$26.82 | -$1,310,620.63 |
0
|
Scheduled
|
Nov 20 - Nov 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
$20.32 | -$492,625.00 |
0
|
Scheduled
|
Jun 15
| ||
Form 4
|
—
|
0
|
$16.74 | -$161,294.00 |
0
|
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$16.70 | -$160,849.68 |
0
|
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
$14.11 | -$134,950.00 |
0
|
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
$11.30 | -$106,911.74 |
0
|
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$14.95 | -$143,335.28 |
0
|
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Biohaven Ltd. (BHVN) Snapshot price: $37
SVP, Clinical OperationsKimberly Gentile owns 95,969 units of Common Shares which is worth $3,550,853.00. From 2022 to 2024 Kimberly Gentile acquired a total of 133,461 shares in Biohaven Ltd. at a cost of $281,159.96, Kimberly also disposed a total of 37,492 shares of Biohaven Ltd. equalling to $262,444.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
|
∞
| 95.97K |
$4.72 | $18,715.96 | 95.97K |
Oct 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||